UAS Laboratories

What UAS Laboratories does

UAS Laboratories (UAS Labs) is a privately-held US specialty biotechnology company founded in 1979 and headquartered in Wausau, Wisconsin. The company operates in the human health probiotics and functional ingredients market, manufacturing probiotic strains and formulated probiotic ingredients — with a particular emphasis on Bacillus coagulans — for sale to B2B customers in the dietary supplement, functional food/beverage, and nutraceutical sectors. UAS Labs does not appear to sell under its own consumer brand; instead, it functions as an upstream ingredient supplier to brand owners who incorporate UAS strains into finished products. The company employs 101-250 people, consistent with a mid-sized specialty ingredients manufacturer.

UAS Labs' business model is anchored in B2B ingredient supply contracts, where revenue mechanics depend on volume orders of bulk probiotic powders, blends, and branded strain ingredients (e.g., its GanedenBC30 Bacillus coagulans technology). The company monetizes through strain licensing, custom fermentation, and supply of finished probiotic ingredients rather than direct-to-consumer sales or subscription models. Pricing details, contract structures, and customer segment mixes are not disclosed in the source materials, limiting visibility into margin profile and customer economics.

From a corporate development perspective, UAS Labs has been an active capital and M&A participant. The company raised approximately $45.5M across three financing rounds between 2017 and 2019, and acquired Micropharma (a Canadian probiotics company) in December 2014 for an undisclosed amount. The company is founder-led, with S.K. Dash serving as Chairman and Founder, supported by CFO and COO functions. Operating geographies and end-customer concentration are not disclosed in the input data, though the probiotics end-markets served are explicitly global in scope.

Name

UAS Laboratories

Website

https://uaslabs.com

Company type

Private

Founded year

1979

Operating status

Operating

Headcount range

101–250 employees

Short description

UAS Laboratories is a US-based probiotic ingredient manufacturer founded in 1979, producing Bacillus coagulans and other proprietary probiotic strains for B2B customers in the dietary supplement and functional food industries.

Ownership category

akta.pro rank

Product category

Probiotic Ingredients & Dietary Supplement Manufacturing

NAICS

Food Manufacturing (311)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Probiotics (Strains, Spore-Formers, Synbiotic Components) (AFAJAKAE)

akta.pro secondary industries

Probiotics & Digestive Health Supplements (CRADAGAF), Probiotic/Fermented Functional Cultured Dairy (Added Cultures/Prebiotics) Manufacturing (AFAHADAJ), Probiotic & Live-Culture Beverage Production (Shots, Tonics) (AFAFAHAE)

Keywords

• Probiotic ingredients
• Dietary supplement manufacturing
• Bacillus coagulans strains
• Live biotherapeutic products
• Probiotic contract manufacturing

Headquarters

HQ city

Wausau

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales

Core offering

UAS Laboratories develops, manufactures, and supplies probiotic strains, formulations, and ingredient solutions for use in dietary supplements, functional foods, and gut-health products. The company serves as a probiotic innovation partner to brand owners and contract manufacturers, with documented expertise in Bacillus coagulans and other clinically studied strains.

Differentiator

Problem solved

Functional benefit

Products and services

• Probiotic Strain Ingredients Bulk probiotic strain ingredients (including Bacillus coagulans-based strains) supplied to dietary supplement and functional food manufacturers for incorporation into finished consumer products.
• Bacillus coagulans Probiotic Line Specialty Bacillus coagulans probiotic ingredients and formulations offered to brand owners and contract manufacturers targeting gastrointestinal, immune, and women's health applications.
• Live Biotherapeutic Product Manufacturing Contract manufacturing services for live biotherapeutic products and microbiome-based formulations, supporting brand customers developing regulated and clinically positioned probiotic offerings.

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators5 records

Recent moves4 records

Expansion highlights4 records

Broad incumbents

• Kerry Group: Global taste and nutrition company with a meaningful probiotic and functional ingredient offering for food, beverage, and supplement manufacturers; overlaps with UAS Labs on customer base but competes from a much broader portfolio.
• Danone: Global dairy and plant-based foods major with proprietary probiotic brands (Actimel, Activia) and an internal probiotic strain program; while primarily a downstream CPG player, Danone also commercializes probiotic strains and competes for shelf space with UAS Labs' customers.
• ADM (Archer Daniels Midland): Global nutrition and agricultural ingredients giant that markets a portfolio of probiotic strains and functional food ingredients to the same CPG, beverage, and supplement customers UAS Labs serves, but as part of a vastly broader ingredients portfolio.

Direct peers

• Sabinsa: US-based nutraceutical ingredient manufacturer with a growing probiotic portfolio alongside branded botanicals and minerals, directly competing with UAS Labs in the dietary supplement B2B ingredient channel.
• BioGaia: Swedish probiotic specialist focused on Lactobacillus reuteri strains sold as both proprietary branded products and B2B ingredient offerings — closely comparable to UAS Labs in strain-focused R&D and global supplement distribution.
• AB Biotics: Spanish probiotic and microbiome company developing proprietary probiotic strains for the nutraceutical and functional food industries, with comparable strain-discovery and B2B ingredient supply dynamics to UAS Labs.
• Probi: Swedish B2B probiotic ingredient and CDMO supplier offering clinically documented Lactobacillus strains to dietary supplement and functional food manufacturers, directly comparable to UAS Labs' B2B ingredient model.
• Novonesis: Formed from the merger of Novozymes and Chr. Hansen, Novonesis is the world's largest probiotic and biosolutions ingredient manufacturer, supplying documented probiotic strains, HMOs, and enzymes across dietary supplements, early life nutrition, and precision proteins — the same product/customer matrix UAS Labs competes in.
• Lallemand Health Solutions: Canadian-based probiotic manufacturer producing documented probiotic strains and yeast-based ingredients for the dietary supplement and functional food markets, with similar B2B strain-supply economics and global brand customers as UAS Labs.

Regional players

• Morinaga Milk Industry: Japanese dairy and functional ingredient company with a dedicated probiotic and bifidobacteria B2B business serving APAC supplement and dairy customers; comparable technology stack to UAS Labs but primarily regional rather than globally head-to-head.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds3 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about UAS Laboratories